European Pharmacopoeia (EP) (Ph. Eur.) Solutions and Reagents

European Pharmacopoeia (EP) solutions and reagents ensure that pharmaceutical products meet the high-quality standards set by the European Union. These solutions are critical in testing the purity, potency, and quality of drugs. CymitQuimica offers a comprehensive range of Ph. Eur.-compliant solutions and reagents, supporting pharmaceutical research and quality control processes.

20
- 50
- 100
- 200

products per page. 9315 products on this category.

Product data	Purity	Price range	Estimated delivery
Ramipril impurity D CRS REF: 41-R0145020CAS: 108731-95-9	- - -	115.00 €	Tue 10 Dec 24
Glycerol formal CRS REF: 41-Y0001391CAS: 4740-78-7	- - -	115.00 €	Tue 10 Dec 24
Phenylephrine hydrochloride CRS REF: 41-P1250000CAS: 61-76-7	- - -	115.00 €	Tue 10 Dec 24
Finasteride for peak identification CRS REF: 41-Y0001604	- - -	115.00 €	Tue 10 Dec 24
Alfuzosin hydrochloride CRS REF: 41-A0325800CAS: 81403-68-1	- - -	115.00 €	Tue 10 Dec 24
Cinnarizine impurity mixture CRS REF: 41-Y0002482	- - -	115.00 €	Tue 10 Dec 24
Fludrocortisone acetate for system suitability CRS REF: 41-Y0002478	- - -	115.00 €	Tue 10 Dec 24
Fludrocortisone acetate for peak identification CRS REF: 41-Y0002475CAS: 514-36-3	- - -	115.00 €	Tue 10 Dec 24
Atomoxetine hydrochloride CRS REF: 41-Y0001586CAS: 82248-59-7	- - -	115.00 €	Tue 10 Dec 24
Stanozolol CRS REF: 41-S1250000CAS: 10418-03-8	- - -	115.00 €	Tue 10 Dec 24
Tristearin CRS REF: 41-T2501200CAS: 555-43-1	- - -	115.00 €	Tue 10 Dec 24
Gonadorelin for NMR identification CRS REF: 41-Y0001546CAS: 33515-09-2	- - -	115.00 €	Tue 10 Dec 24
Fusidic acid for peak identification CRS REF: 41-Y0001394CAS: 6990-06-3	- - -	115.00 €	Tue 10 Dec 24
Human Plasma Pools for NAT validation CRS REF: 41-H1005000	- - -	607.00 €	Tue 10 Dec 24
Trichlorotrifluoroethane CRS - * ODS REF: 41-T1985000CAS: 76-13-1	- - -	115.00 €	Tue 10 Dec 24
Diclazuril CRS REF: 41-Y0002342CAS: 101831-37-2	- - -	152.00 €	Tue 10 Dec 24
Cefpodoxime proxetil CRS REF: 41-Y0001305CAS: 87239-81-4	- - -	115.00 €	Tue 10 Dec 24
Lacosamide impurity F CRS REF: 41-Y0001989	- - -	115.00 €	Tue 10 Dec 24
Sulfapyridine CRS REF: 41-S2159100CAS: 144-83-2	- - -	115.00 €	Tue 10 Dec 24
Orientvine stem HRS REF: 41-Y0001501CAS: 115-53-7	- - -	115.00 €	Tue 10 Dec 24

European Pharmacopoeia (EP) (Ph. Eur.) Solutions and Reagents

Ramipril impurity D CRS

Ref: 41-R0145020

Glycerol formal CRS

Ref: 41-Y0001391

Phenylephrine hydrochloride CRS

Ref: 41-P1250000

Finasteride for peak identification CRS

Ref: 41-Y0001604

Alfuzosin hydrochloride CRS

Ref: 41-A0325800

Cinnarizine impurity mixture CRS

Ref: 41-Y0002482

Fludrocortisone acetate for system suitability CRS

Ref: 41-Y0002478

Fludrocortisone acetate for peak identification CRS

Ref: 41-Y0002475

Atomoxetine hydrochloride CRS

Ref: 41-Y0001586

Stanozolol CRS

Ref: 41-S1250000

Tristearin CRS

Ref: 41-T2501200

Gonadorelin for NMR identification CRS

Ref: 41-Y0001546

Fusidic acid for peak identification CRS

Ref: 41-Y0001394

Human Plasma Pools for NAT validation CRS

Ref: 41-H1005000

Trichlorotrifluoroethane CRS - * ODS

Ref: 41-T1985000

Diclazuril CRS

Ref: 41-Y0002342

Cefpodoxime proxetil CRS

Ref: 41-Y0001305

Lacosamide impurity F CRS

Ref: 41-Y0001989

Sulfapyridine CRS

Ref: 41-S2159100

Orientvine stem HRS

Ref: 41-Y0001501